Publications

The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors. Spakowicz, D., Dravillas C., et al

Inherited germline variants in urinary tract cancer: A multicenter whole-exome sequencing analysis and correlation with clinical features and tumor genomics. Kohlmann W., Nix D., et al

The tumor microbiome reacts to hypoxia and can influence response to radiation treatment in colorectal cancer. Benej M., Hoyd R., Spakowicz D., et al

Differences in Co-Expression of T Cell Co-Inhibitory and Co-Stimulatory Molecules with PD-1 Across Different Human Cancers. Tarhini A., Hedges D., Tan A.C., et al

Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database. Eule, C., Hu J., Hedges D., et al

CHEK2 founder variants and thyroid cancer risk. Brock P., Liynarachchi S., et al.

Profiling the molecular and clinical landscape of glioblastoma utilizing the ORIEN brain cancer database. Demetriou A., Chow F., et al.

Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages. Mandula J., Sierra-Mondragon R., et al.

Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study. Hutchcraft, M., Zhang, S., et al.

Genomic Classification and Individualized Prognosis in Multiple Myeloma. Maura, F., Rajanna, A.R., et al.